Eledon Pharmaceuticals Inc (ELDN)
Working Capital Ratio
64.48%
Quarterly · Period ending:
ELDN Working Capital Ratio
Latest reported64.48%period ending
Latest reported64.48%period ending
ELDN Quarterly Working Capital Ratio (92.82% → 64.48%)
Quarterly working capital ratio
High-resolution chart · PNG
ELDN working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 64.4773% | |
| 68.2608% | |
| 69.4306% | |
| 63.1502% | |
| 67.4113% | |
| 73.4824% | |
| 74.4923% | |
| 60.2395% | |
| 67.3921% | |
| 54.1092% | |
| 58.6464% | |
| 62.5509% | |
| 64.3555% | |
| 52.7616% | |
| 57.1627% | |
| 40.9697% | |
| 44.9317% | |
| 47.3218% | |
| 49.2207% | |
| 51.6521% | |
| 54.2063% | |
| 55.3182% | |
| 57.3811% | |
| 56.5833% | |
| 82.5064% | |
| 80.1385% | |
| 79.1236% | |
| 69.8843% | |
| 72.6449% | |
| 52.6355% | |
| 68.9651% | |
| 77.8151% | |
| 85.4605% | |
| 86.4645% | |
| 84.0513% | |
| 81.3632% | |
| 80.7741% | |
| 89.861% | |
| 89.7954% | |
| 81.6699% | |
| 81.8853% | |
| 88.0437% | |
| 89.752% | |
| 91.7546% | |
| 93.9355% | |
| 93.7175% | |
| 95.8457% | |
| 94.7365% | |
| 77.0751% | |
| 92.8206% |